is hers glp-1 legit Despite the Stigma, Hims & Isn't Backing Away From Weight-Loss Drugs People who used Hers, how

Skin texture, lighting, body proportions: all are generated to mimic a plausible journey, often showing a woman in her 40s or 50s, the demographic currently driving Europes GLP-1 interest

Benign adaptation looks mild, intermittent, and self-limiting by comparison

The FDA has approved specific formulations for different indications: semaglutide 2.4 mg (Wegovy), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) are approved for chronic weight management, while all are approved for diabetes at different doses

These findings support the concept that glucagon receptor activation may be therapeutically useful when balanced by GLP-1 receptor signaling, although retatrutide currently provides the most prominent evidence for triple receptor agonism

Sig Transduct Target Ther 10 , 239 (2025)